Christopher D Riemann MD

Retinal Disease

Member, Board of Directors - Cincinnati Eye Institute Director, Vitreoretinal Fellowship - Cincinnati Eye Institute and University of Cincinnati Section Head Ophthalmology, Bethesda North Hospital

Join to view full profile

1945 Cei DriveCincinnati, OH 45242
Phone+1 513-984-5133
Fax+1 513-569-3941

Dr. Riemann is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Riemann's full profile Already have an account?

Education & Training

Cleveland Clinic FoundationResidency, Ophthalmology, 1995 - 1998
York HospitalInternship, Transitional Year, 1994 - 1995
University of Maryland School of MedicineClass of 1994

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

OH State Medical License 1995 - 2028
KY State Medical License 1999 - 2027
PA State Medical License 1994 - 1995
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013-2017
CMS Meaningful Use Stage 2 Certification NextGen Patient Portal, NextGen Healthcare, 2013-2017
CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013-2017

Clinical Trials

Treatment for Presumed Ocular Histoplasmosis
UNKNOWN
PHASE1, PHASE2

Publications & Presentations

PubMed

Management of Anteriorly Migrated Fluocinolone 0.18- & 0.19-mg Implants Using Scleral Suture Fixation With and Without Concomitant Implantation of A Fluocinolone 0.59-...
Tiffany C Nguyen, Cynthia K McClard, Christopher D Riemann
Retinal Cases & Brief Reports. 2026-07-01
Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study.
Michael A Singer, Charles C Wykoff, Christopher D Riemann, Victor H Gonzalez, Christina Y Weng
Ophthalmology. 2026-07-01
REPLY.
Michael A Singer, Charles C Wykoff, Christopher D Riemann, Victor H Gonzalez, Christina Y Weng
Ophthalmology. 2026-06-12

Press Mentions

OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025June 23rd, 2025
RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025May 12th, 2025
Ergonomics: Care for Yourself to Improve Patient CareAugust 31st, 2022